Does POMALIDOMIDE Cause Hypercalcaemia? 229 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 229 reports of Hypercalcaemia have been filed in association with POMALIDOMIDE (Pomalyst). This represents 0.3% of all adverse event reports for POMALIDOMIDE.
229
Reports of Hypercalcaemia with POMALIDOMIDE
0.3%
of all POMALIDOMIDE reports
84
Deaths
165
Hospitalizations
How Dangerous Is Hypercalcaemia From POMALIDOMIDE?
Of the 229 reports, 84 (36.7%) resulted in death, 165 (72.1%) required hospitalization, and 29 (12.7%) were considered life-threatening.
Is Hypercalcaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POMALIDOMIDE. However, 229 reports have been filed with the FAERS database.
What Other Side Effects Does POMALIDOMIDE Cause?
Plasma cell myeloma (7,023)
Death (6,795)
Fatigue (6,530)
Pneumonia (5,792)
Off label use (3,845)
Diarrhoea (3,351)
White blood cell count decreased (3,328)
Neutropenia (3,029)
Rash (2,715)
Dyspnoea (2,543)
What Other Drugs Cause Hypercalcaemia?
RITUXIMAB (857)
METHOTREXATE (803)
ADALIMUMAB (663)
TOCILIZUMAB (618)
ABATACEPT (612)
ETANERCEPT (602)
DENOSUMAB (599)
ALENDRONATE (594)
INFLIXIMAB (594)
LEFLUNOMIDE (585)
Which POMALIDOMIDE Alternatives Have Lower Hypercalcaemia Risk?
POMALIDOMIDE vs POMALYST
POMALIDOMIDE vs PONATINIB
POMALIDOMIDE vs PONATINIB\PONATINIB
POMALIDOMIDE vs PONESIMOD
POMALIDOMIDE vs PORACTANT ALFA